tazarotene has been researched along with Erythema in 11 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The adapalene arm was also therapeutically similar to the tazarotene arm in terms of the percent reduction in inflammatory and noninflammatory lesion counts at week 12, as well as in the assessments of acne severity and improvement." | 6.73 | Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris. ( Arsonnaud, S; Soto, P; Thiboutot, D, 2008) |
| "Adapalene gel was associated with fewer treatment-related adverse events than tazarotene cream (36% versus 58%, respectively), and less than half as many adverse events that were "definitely" related to study treatment than tazarotene cream (20% versus 45%, respectively)." | 6.73 | Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris. ( Colón, LE; Gottschalk, RW; Johnson, LA; Pariser, D, 2008) |
| " Treatment-related adverse effects were generally limited to mild or moderate local irritation and were less frequent with the treatment regimen administered once daily." | 6.69 | The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. ( Chandraratna, RA; Drake, LA; Elias, PM; Guzzo, C; Krueger, GG; Lew-Kaya, DA; Lowe, NJ; Lue, JC; Sefton, J; Weinstein, GD, 1998) |
| "Both tazarotene gels were as effective as fluocinonide in reducing plaque elevation after 1 week of treatment, and tazarotene 0." | 6.69 | Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. ( Ast, E; Callen, JP; Chandraratna, RA; Cullen, SI; Gibson, JR; Hong, SR; Kulp-Shorten, CL; Lebwohl, M; Lowe, NJ; Lue, JC; Phillips, TJ; Quell, JM; Rosen, T; Sefton, J; Wolf, DI, 1998) |
| "Topical retinoids, such as adapalene gel and tazarotene cream, are considered first-line therapy for the treatment of acne vulgaris." | 5.13 | Is switching retinoids a sound strategy for the treatment of acne vulgaris? ( Colón, LE; Gold, LS; Gottschalk, RW; Johnson, LA, 2008) |
| "Erythema was significantly more severe (P=0." | 2.76 | Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm. ( Galitzer, BI, 2011) |
| "The adapalene arm was also therapeutically similar to the tazarotene arm in terms of the percent reduction in inflammatory and noninflammatory lesion counts at week 12, as well as in the assessments of acne severity and improvement." | 2.73 | Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris. ( Arsonnaud, S; Soto, P; Thiboutot, D, 2008) |
| "Adapalene gel was associated with fewer treatment-related adverse events than tazarotene cream (36% versus 58%, respectively), and less than half as many adverse events that were "definitely" related to study treatment than tazarotene cream (20% versus 45%, respectively)." | 2.73 | Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris. ( Colón, LE; Gottschalk, RW; Johnson, LA; Pariser, D, 2008) |
| " Treatment-related adverse effects were generally limited to mild or moderate local irritation and were less frequent with the treatment regimen administered once daily." | 2.69 | The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. ( Chandraratna, RA; Drake, LA; Elias, PM; Guzzo, C; Krueger, GG; Lew-Kaya, DA; Lowe, NJ; Lue, JC; Sefton, J; Weinstein, GD, 1998) |
| "Both tazarotene gels were as effective as fluocinonide in reducing plaque elevation after 1 week of treatment, and tazarotene 0." | 2.69 | Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. ( Ast, E; Callen, JP; Chandraratna, RA; Cullen, SI; Gibson, JR; Hong, SR; Kulp-Shorten, CL; Lebwohl, M; Lowe, NJ; Lue, JC; Phillips, TJ; Quell, JM; Rosen, T; Sefton, J; Wolf, DI, 1998) |
| " Our purpose is to compare the rates of adverse events associated with different topical psoriasis treatments." | 2.42 | A systematic review of adverse effects associated with topical treatments for psoriasis. ( Bruner, CR; Feldman, SR; Fleischer, AB; Ventrapragada, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| He, C | 1 |
| Jin, H | 1 |
| Liu, X | 1 |
| Hu, F | 1 |
| Zhang, L | 2 |
| Zhang, S | 1 |
| He, Y | 1 |
| Yang, X | 1 |
| Chen, H | 1 |
| Wang, X | 1 |
| Ji, C | 1 |
| Lv, C | 1 |
| Miao, G | 1 |
| Li, X | 2 |
| Diao, Q | 1 |
| Li, L | 1 |
| Li, Y | 1 |
| Wang, R | 1 |
| Zhou, X | 1 |
| Xia, X | 1 |
| Yan, M | 1 |
| Song, J | 1 |
| Zhang, R | 1 |
| Geng, L | 1 |
| Zheng, M | 1 |
| Lu, Q | 1 |
| Lu, T | 1 |
| Shi, Y | 1 |
| Jing, H | 1 |
| Zhang, X | 1 |
| Shi, J | 1 |
| Xia, J | 1 |
| Gao, Y | 1 |
| Wang, Y | 1 |
| Mouchard, A | 1 |
| Tallegas, M | 1 |
| Machet, MC | 1 |
| Machet, L | 1 |
| Cornillier, H | 1 |
| Thiboutot, D | 1 |
| Arsonnaud, S | 2 |
| Soto, P | 2 |
| Pariser, D | 1 |
| Colón, LE | 2 |
| Johnson, LA | 2 |
| Gottschalk, RW | 2 |
| Gold, LS | 1 |
| Galitzer, BI | 1 |
| Bruner, CR | 1 |
| Feldman, SR | 1 |
| Ventrapragada, M | 1 |
| Fleischer, AB | 1 |
| Greenspan, A | 1 |
| Loesche, C | 1 |
| Vendetti, N | 1 |
| Georgeian, K | 1 |
| Gilbert, R | 1 |
| Poncet, M | 1 |
| Baker, MD | 1 |
| Dosik, JS | 1 |
| Homer, K | 1 |
| Krueger, GG | 1 |
| Drake, LA | 1 |
| Elias, PM | 1 |
| Lowe, NJ | 2 |
| Guzzo, C | 1 |
| Weinstein, GD | 1 |
| Lew-Kaya, DA | 1 |
| Lue, JC | 2 |
| Sefton, J | 2 |
| Chandraratna, RA | 2 |
| Lebwohl, M | 1 |
| Ast, E | 1 |
| Callen, JP | 1 |
| Cullen, SI | 1 |
| Hong, SR | 1 |
| Kulp-Shorten, CL | 1 |
| Phillips, TJ | 1 |
| Rosen, T | 1 |
| Wolf, DI | 1 |
| Quell, JM | 1 |
| Gibson, JR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Excimer Laser Combined With Either Topical Tazarotene or Topical Betamethasone Valerate Versus Excimer Laser Alone in Treatment of Localized Chronic Plaque Psoriasis; Clinical and Dermoscopic Study[NCT05555797] | Phase 4 | 30 participants (Anticipated) | Interventional | 2022-10-30 | Not yet recruiting | ||
| Spray® and Vectical Ointment® in the Treatment of Plaque Psoriasis[NCT01205880] | Phase 4 | 12 participants (Actual) | Interventional | 2009-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tazarotene and Erythema
| Article | Year |
|---|---|
A systematic review of adverse effects associated with topical treatments for psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Dermatologic Agen | 2003 |
8 trials available for tazarotene and Erythema
| Article | Year |
|---|---|
Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Do | 2008 |
Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Erythe | 2008 |
Is switching retinoids a sound strategy for the treatment of acne vulgaris?
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Do | 2008 |
Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Dermatologic Agents; Erythe | 2011 |
Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
Topics: Adapalene; Adult; Aged; Dermatologic Agents; Double-Blind Method; Drug Interactions; Erythema; Femal | 2003 |
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.
Topics: Acne Vulgaris; Adapalene; Adult; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Drug A | 2005 |
The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.
Topics: Administration, Cutaneous; Adult; Dermatologic Agents; Double-Blind Method; Drug Administration Sche | 1998 |
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-In | 1998 |
2 other studies available for tazarotene and Erythema
| Article | Year |
|---|---|
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatologic Agents; Drug | 2021 |
Erythematous Papular Lesions on the Neck: A Quiz.
Topics: Administration, Cutaneous; Adolescent; Dermatologic Agents; Erythema; Humans; Male; Neck; Nicotinic | 2018 |